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Abstract
TRPC are nonselective cation channels involved in calcium entry. Their regulation by phosphorylation has been shown to
modulate their routing and activity. TRPC6 activity increases following phosphorylation by Fyn, and is inhibited by protein
kinase G and protein kinase C. A previous study by our group showed that TRPC6 is phosphorylated under unstimulated
conditions in a human embryonic kidney cells line (HEK293). To investigate the mechanism responsible for this
phosphorylation, we used a MS/MS approach combined with metabolic labeling and showed that the serine at position 814
is phosphorylated in unstimulated cells. The mutation of Ser
814 into Ala decreased basal phosphorylation but did not modify
TRPC6 activity. Even though Ser
814 is within a consensus site for casein kinase II (CK2), we showed that CK2 is not involved in
the phosphorylation of TRPC6 and does not modify its activity. In summary, we identified a new basal phosphorylation site
(Ser
814) on TRPC6 and showed that CK2 is not responsible for the phosphorylation of this site.
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Introduction
Calcium homeostasis is crucial for every cell type, and its tight
regulation allows intracellular calcium to be a widely used second
messenger [1]. This regulation is a fine balance between calcium
entry from the extracellular medium, release from intracellular
stores, and extrusion through the activity of pumps or exchangers.
TRP (transient receptor potentials) are plasma membrane-
embedded calcium channels that were first discovered in Drosophila
melanogaster. Up to 28 mammalian isoforms of dTRP have been
cloned so far and have been distributed into six subfamilies
(TRPC, TRPV, TRPM, TRPP, TRPML, and TRPA) [2].
TRPCs are the closest subfamily to dTRP and include seven
members (TRPC1 to TRPC7). Their role as calcium channels has
been well characterized, but their exact activation and regulation
mechanisms have yet to be fully understood. Along with STIM
and Orai, TRPCs are involved in store-operated and receptor-
operated calcium entry following hormonal stimulation of Gq-
protein coupled receptor or receptor tyrosine kinase [3]. These
receptors activate phospholipase Cb or phospholipase Cc, which
hydrolyze phosphatidylinositol-4,5-bisphosphate into diacylgly-
cerol and inositol 1,4,5-trisphosphate. inositol 1,4,5-trisphosphate
activates its receptor on the endoplasmic reticulum to induce
calcium release. Store depletion and diacylglycerol formation
activate channels located at the plasma membrane to induce Ca
2+
entry as long as the stimulation is maintained. TRPC6 is one of
these Ca
2+ entry channels [4]. A dysregulation of TRPC6 has been
associated with idiopathic pulmonary arterial hypertension [5,6],
focal segmental glomerulosclerosis [7,8], and hyperproliferation of
cancer cells [9]. Understanding the mechanisms regulating
TRPC6 activity and routing is thus essential to better treat or
prevent these pathologies.
Post-translational modification of TRPCs has been shown to
influence their activity and routing. Following EGFR activation,
TRPC6 is phosphorylated by Fyn, a Src family protein tyrosine
kinase. Phosphorylation by Fyn allows optimal activation of
TRPC6 [10]. Protein kinase G phosphorylates TRPC6 on Thr
69,
thus decreasing its channel activity [11]. Protein kinase C
phosphorylates TRPC6 on Ser
768 [12] and Ser
448 [13]. We have
shown that protein kinase C-dependent phosphorylation of
TRPC6 on Ser
448 decreases its activity and that TRPC6 is
phosphorylated under basal conditions [13]. The purpose of the
present study was to investigate the mechanism responsible for this
basal phosphorylation of TRPC6. Using a mass spectrometry
approach, we found out that the Ser
814 was phosphorylated and
contributed to 50% of the basal phosphorylation state of TRPC6.
Surprisingly, mutant TRPC6
S814A displayed an activity similar to
that of wild-type TRPC6. As Ser
814 is within a consensus sequence
for phosphorylation by CK2, we used two CK2 inhibitors to
investigate the possible involvement of this kinase. However, the
inhibition of CK2 did not modify the phosphorylation state or
activity of TRPC6. Thus, we have identified a new phosphory-
lation site on TRPC6.
Results
HEK293 cells stably expressing TRPC6 (HEK293 T6.11) were
solubilized, and TRPC6 was immunoprecipitated using an anti-
hemagglutinin (HA) antibody and size fractionated by SDS-
PAGE. The gel was stained with colloidal Brilliant Blue, and the
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digested with trypsin. Tryptic fragments were analyzed by LC-
MS/MS and identified by database searches using the Mascot
search engine. Sequence coverage of TRPC6 totaled 68.1%
(77.8% of intracellular regions) (n = 2) (Fig. 1B). Nano-LC-MS/
MS analyses and MS spectra revealed that Ser
814, located in the
C-terminus, was phosphorylated with an Ascore of 57.75. An
Ascore of 20 or more means that the phosphorylation is on that
particular residue with a probability of 99%, and not on another
serine, threonine, or tyrosine that may be present on the peptide
[18]. Figure 1C shows the tandem mass spectrometry (MS/MS)
spectrum of phosho-Ser
814.
To confirm that Ser
814 was phosphorylated under unstimulated
conditions, we substituted it for an alanine. HEK293 cells were
transiently transfected with the HA-tagged TRPC6 or
TRPC6
S814A mutant and metabolically labeled with inorganic
32P. HA-tagged proteins were then immunoprecipitated with an
anti-HA antibody and size fractionated by SDS-PAGE. The
phosphorylation states of the proteins were revealed by autoradi-
ography. Under basal conditions, the level of phosphorylation of
mutant TRPC6
S814A corresponded to 52.8628.0% of that of WT
TRPC6 (Fig. 2A and 2B). Mutation did not significantly alter the
overall expression of TRPC6 (Fig. 2A, lower panel). Thus, as the
substitution of Ser
814 for Ala decreased the basal phosphorylation
of TRPC6 by only 50%, these results suggested that Ser
814 is a
major phosphorylation site under unstimulated conditions. These
results further suggest the existence of another unknown
phosphorylation site on TRPC6.
We next assessed the effect of the phosphorylation of Ser
814 on
the activity of TRPC6. HEK293 cells were transiently transfected
with the M5 muscarinic receptor and with TRPC6 or its mutant
TRPC6
S814A.C a
2+ entry through TRPC6 was analyzed using the
standard Ca
2+ depletion/restoration protocol [4]. Cells were
incubated for 30 s in Ca
2+-free medium containing 0.5 mM
EGTA before depleting the intracellular Ca
2+ stores with 5 mM
carbachol (CCh). Once the [Ca
2+]i had returned to the basal level
(2 min after the addition of CCh), the extracellular medium was
replaced with medium containing 1.8 mM CaCl2. Figure 3A
shows that, in the absence of extracellular Ca
2+, CCh-induced
Ca
2+ release was similar in TRPC6-, TRPC6
S814A-, and mock-
transfected cells. When 1.8 mM CaCl2 was added to TRPC6- and
TRPC6
S814A-transfected cells, Ca
2+ entry raised the [Ca
2+]i to a
plateau level of approximately 250 nM and 260 nM, respectively
(Fig. 3A). In mock-transfected cells, Ca
2+ entry raised the [Ca
2+]i
to a lower plateau level of approximately 210 nM. Figure 3B
shows the relative net Ca
2+ entry, which was calculated by
subtracting the basal [Ca
2+]i from the maximal [Ca
2+]i recorded
after the extracellular Ca
2+ had been restored. Compared to the
endogenous net Ca
2+ entry in mock-transfected cells, the
expression of TRPC6 enhanced CCh-induced net Ca
2+ entry to
127615% (n = 6). Expression of TRPC6
S814A gave similar
results, with an increase of CCh-induced net Ca
2+ entry reaching
131617% (n = 6). The substitution of Ser
814 for Ala did not
modify the level of expression of TRPC6 nor its amount at the
plasma membrane (Fig. 4). These results suggested that the basal
phosphorylation of TRPC6 on Ser
814 does not affect channel
activity.
An analysis of the amino acid sequence surrounding Ser
814 of
TRPC6 revealed that this region is a consensus site for CK2
substrate recognition (Ser/Thr-X-X-Glu/Asp) [24]. To verify
whether CK2 is responsible for the phosphorylation of Ser
814 of
TRPC6 under basal conditions, we used two selective CK2
inhibitors, DMAT (2-dimethylamino-4,5,6,7-tetrabromo-1H-benz-
imidazole) and TBCA ((E)-3-(2,3,4,5-tetrabromophenyl)acrylic
acid). T6.11 cells were metabolically labeled with inorganic
32P
for 4 h in the presence of either 10 mM DMAT or 10 mM TBCA.
TRPC6 was then immunoprecipitated with an anti-HA antibody
and size fractionated by SDS-PAGE, and its phosphorylation state
was revealed by autoradiography. Figure 5A shows that neither
DMAT nor TBCA prevented or attenuated the phosphorylation
state of TRPC6. The relative phosphorylation of TRPC6 incubated
with DMAT and TBCA was 0.9560.22% and 1.0660.32%,
respectively, of its phosphorylation state in untreated cells (Fig. 5B).
Despite the fact that CK2 did not directly alter the
phosphorylation state of TRPC6, we investigated whether this
kinase could have a possible indirect role in Ca
2+ signaling. In
T6.11 cells, incubation for 4 h with DMAT and TBCA
potentiated CCh-induced Ca
2+ release by approximately 30%.
However, after calcium restoration, DMAT and TBCA did not
significantly alter CCh-induced Ca
2+ entry (Fig. 6A). Compared to
untreated cells, net CCh-induced Ca
2+ entry in DMAT-treated
cells was 8965%, whereas it was 99611% in TBCA-treated cells.
A possible role for CK2 was also investigated in A7r5 cells. These
cells endogenously express a high level of TRPC6, and their
vasopressin (AVP)-induced Ca
2+ entry is mostly through TRPC6
[25,26,27]. In A7r5 cells, a 4 h preincubation with 10 mM DMAT
did not modify AVP-induced Ca
2+ release (data not shown) or
AVP-induced Ca
2+ entry (Fig. 6C). These results thus exclude a
role for CK2 in the direct and/or indirect regulation of TRPC6
activity.
Discussion
Basal phosphorylation of TRPC6 has been previously observed
in resting platelets and in TRPC6 stably expressed in HEK293
cells [28,29], but the phosphorylated residue has not been
identified. Using a mass spectrometry approach, we found out
that Ser
814 was phosphorylated under basal conditions in HEK293
cells. Mutation of the Ser
814 into alanine caused a 50% decrease of
basal incorporation of
32P in TRPC6. This phosphorylation
occurred during metabolic labeling experiments, in which cells
were serum starved for 4 hours and not exposed to any kind of
stimulus. The 50% decrease of basal incorporation of
32Pi n
TRPC6
S814A suggests that Ser
814 is a major phosphorylation site
under unstimulated conditions and that at least one other site is
phosphorylated. Our MS/MS approach yielded 78% coverage of
the intracellular regions of TRPC6. However, due to technical
limitations, some large peptides were not identified. Of these, three
peptides were located in the N-terminus, two peptides were
located in intracellular loops, and one peptide was located in the
C-terminus. Overall, these uncovered regions contained 17
phosphorylatable residues (Ser, Thr, or Tyr). Further studies are
needed to verify whether one of these residues is phosphorylated
under unstimulated conditions.
A recent study, which used an MS/MS approach similar to
ours, revealed that Drosophila TRP is phosphorylated under
unstimulated (dark) conditions [30]. They showed that Ser
721
and Ser
936 are highly phosphorylated in the dark, and that Ser
936
is dephosphorylated in the presence of light, a phenomenon that
requires the activation of the phototransduction cascade. Our
study showed that Ser
814 of TRPC6 is phosphorylated under
unstimulated conditions. However, the mutation of Ser
814 into Ala
did not significantly modify the activity, the level of expression, nor
the trafficking of TRPC6. Ser
814 is localized in a highly
hydrophilic region within the C-terminus of TRPC6, between
the proline rich motif (amino acids 759-770), which binds FKBP12
[31], and the CIRB domain (amino acids 838-872), which binds
calmodulin and inositol 1,4,5-trisphosphate receptor [32,33,34].
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814 might play a role in the
interaction of those proteins with TRPC6 or the folding and
trafficking of the protein, which could be masked in recombinant
cell model. To demonstrate the significance of this phosphoryla-
tion event in a non-recombinant cell model, we need to identify
the kinase involved in the phosphorylation of Ser
814. A sequence
analysis of TRPC6 revealed that Ser
814 is within a consensus site
for phosphorylation by CK2 (S/T-X-X-D/E). Furthermore, CK2
favors an acidic environment as indicated by the results of Meggio
et al., who showed that any acidic residue in positions 22t o+7
favors phosphorylation by CK2 [24]. In TRPC6, a glutamate in
position +2 and an aspartate in position +3 of Ser
814 constitute a
favorable acidic environment for CK2. CK2 is also known to
exhibit constitutive activity, making it a potential kinase for the
basal phosphorylation of Ser
814. Moreover, the subcellular
location and functioning of TRPP2 is modulated by the
phosphorylation by CK2 [35,36]. CK2 can phosphorylate the
NR2B subunit of NMDAR, decreasing its surface expression [37],
or NHE3, stimulating its basal activity [38]. However, we showed
that the inhibition of CK2 by DMAT and TBCA does not reduce
Figure 1. MS/MS identification of potential phosphorylated residues on TRPC6. A, Untreated T6.11 cells were lysed before TRPC6 was
immunoprecipitated using an anti-HA antibody. The immunoprecipitated proteins were then deglycosylated with PNGaseF or not, before being
separated by SDS-PAGE and stained with Colloidal Brilliant Blue. B, Sequence coverage of TRPC6 by nano-LC-MS/MS after tryptic digestion is
highlighted. Ser
814 is shown in white on a black background. The transmembrane segments are underlined. Residues 931 to 939 represent the HA
epitope. Total sequence coverage is 68%. C, Simplified LC-MS/MS spectrum of the FGISGpSHEDLSK peptide from TRPC6 phosphorylated at Ser
814.
The phosphorylation of Ser
814 was confirmed by the mass assignments of fragmentation ions b5, b6, y6, and y7.
doi:10.1371/journal.pone.0018121.g001
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also verified whether CK2 could indirectly regulate Ca
2+ signaling
in TRPC6-expressing cells. It has previously been shown that the
calcium-sensitive potassium channel KCa2.2 loses Ca
2+ sensitivity
following calmodulin phosphorylation by CK2 [39]. However, we
showed that inhibition of CK2 does not modify CCh-induced
Ca
2+ entry into HEK293 cells stably expressing TRPC6 (T6.11)
despite the fact that it does enhance CCh-induced Ca
2+ release.
Similarly, in A7r5 cells expressing high levels of TRPC6, the
inhibition of CK2 with DMAT did not affect AVP-induced Ca
2+
release or Ca
2+ entry. We thus showed that CK2 does not
modulate the activity of TRPC6.
In summary, we showed that the serine in position 814 of
TRPC6 is phosphorylated under basal conditions in HEK293
cells, and that it accounts for one of two distinct basal
phosphorylation sites. Our results further showed that CK2 is
not the kinase responsible for these phosphorylations, and that
CK2 does not directly or indirectly modify TRPC6 activity.
Further studies are needed to demonstrate the significance of the
phosphorylation of Ser
814 under unstimulated conditions and to
identify the kinase responsible for this phosphorylation.
Materials and Methods
Material
Cell culture media, serum, Hepes, trypsin, Opti-MEM I,
LipofectAMINE 2000, and Zero Blunt Topo PCR cloning kits
were purchased from Invitrogen (Burlington, ON, Canada).
Phosphate-free culture media and G418 were from Wisent (St-
Bruno, QC, Canada). NP-40 was from Roche (Laval, QC,
Canada). HEK293 and A7r5 cell lines were from ATCC
(Manassas, VA, USA). DMAT, TBCA, CCh, AVP, phosphatase
cocktail inhibitor set #2, and fura 2/AM were from Calbiochem
(San Diego, CA, USA). Rabbit polyclonal and mouse monoclonal
anti-HA-specific antibodies were from Covance (Berkeley, CA,
USA). Peroxidase-conjugated donkey anti-rabbit antibodies,
peroxidase-conjugated sheep anti-mouse antibodies, protein A-
sepharose CL-4B, and Biomax MR films were from GE
Healthcare (Baie d’Urfe ´, QC, Canada). Western Lightning
Chemiluminescence Reagent Plus, 0.2 mm nitrocellulose mem-
branes, and
32P-orthophosphoric acid were from Perkin–Elmer
Life Sciences (Woodbridge, ON, Canada). All primers and
oligonucleotides were from Integrated DNA Technologies (Coral-
ville, IA, USA). Phusion High-Fidelity DNA polymerase was from
Finnzymes (Espoo, Finland). Restriction enzymes, PNGase F, and
T4 DNA ligase were from New England Biolabs (Pickering, ON,
Canada). Unless otherwise stated, all other reagents were from
Sigma (Oakville, ON, Canada) or Laboratoire MAT (Quebec
City, QC, Canada).
Mass spectrometry
Protein in-gel digestion. Excised acrylamide bands
containing immunoprecipitated and separated TRPC6 were sent
to the Proteomics Platform of the Eastern Quebec Genomics
Center (CHUL Research Center, Quebec City, QC, Canada) for
MS/MS analysis. Proteins were extracted from gels, placed in 96-
well plates, and washed with water. Tryptic digestion was
performed using a MassPrep liquid handling robot (Waters,
Milford, USA) according to the manufacturer’s specifications and
the protocol of Shevchenko et al. [14] with the modifications
suggested by Havlis et al. [15]. Briefly, proteins were reduced with
10 mM DTT and alkylated with 55 mM iodoacetamide. The
trypsin digestion was performed using 105 mM modified porcine
trypsin (sequencing grade, Promega, Madison, WI, USA) at 58uC
for 1 h. Digestion products were extracted using 1% formic acid
and 2% acetonitrile followed by 1% formic acid and 50%
acetonitrile. The recovered extracts were pooled, vacuum
centrifuge dried, resuspended in 8 ml of 0.1% formic acid, and
2 ml was analyzed by mass spectrometry.
Mass spectrometry. Peptide samples were separated by
online reversed-phase nanoscale capillary liquid chromatography
and analyzed by electrospray mass spectrometry. The experiments
were performed using a Thermo Surveyor MS pump connected to
Figure 2. Metabolic labeling of TRPC6 and mutants reveals that Ser814 is phosphorylated. A, Metabolic labeling was carried out as
described in Experimental Procedures. HEK 293T cells transfected with wild-type or mutant TRPC6 were lysed and TRPC6 was immunoprecipitated
using a mouse monoclonal anti-HA antibody (HAm) and separated by SDS-PAGE. The autoradiogram (upper panel) and the immunoblot using a
rabbit polyclonal anti-HA antibody (HAr) (lower panel) are representative of five independent experiments. B, The histogram represents the relative
amount of phosphorylated TRPC6 calculated as the ratio of phospho-TRPC6 (densitometric analysis of autoradiograms) to total TRPC6 (determined
by scanning and quantifying the immunoblot signals) for each sample. The histogram is the average 6 SD of five experiments. *P ,0.03.
doi:10.1371/journal.pone.0018121.g002
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Jose, CA, USA) equipped with a nanoelectrospray ion source
(ThermoFisher). The peptides were separated on a PicoFrit
column (BioBasic C18, 10 cm60.075 mm internal diameter,
New Objective, Woburn, MA, USA) with a 2-50% linear
gradient of solvent B (acetonitrile, 0.1% formic acid) for 30 min
at a flow rate of 200 nL/min (obtained by flow-splitting). Mass
spectra were acquired using a data dependent acquisition mode
using Xcalibur software version 2.0. Each full scan mass spectrum
(400 to 2000 m/z) was followed by collision-induced dissociation
of the seven most intense ions. The dynamic exclusion (30 s
exclusion duration) function was enabled, and the relative
collisional fragmentation energy was set at 35%. All MS/MS
samples were analyzed using Mascot (Matrix Science, London,
UK; version 2.2.0) set up to search for the sequence of mouse
TRPC6 assuming trypsin as the digestion enzyme. Mascot was
searched with a fragment ion mass tolerance of 0.50 Da and a
parent ion tolerance of 2.0 Da. The iodoacetamide derivative of
cysteine was specified as a fixed modification, and the oxidation of
methionine and the phosphorylation of serine, threonine, and
Figure 3. The S814A mutation does not alter TRPC6 activity. A,
[Ca
2+]i was recorded in HEK293T transiently transfected with pcDNA3
(open circles), TRPC6WT (open diamonds), or TRPC6
S814A (closed
squares). The cells were incubated in the absence of extracellular
Ca
2+ (in the presence of 0.5 mM EGTA) for 30 s before being stimulated
with 5 mM CCh. External Ca
2+ (1.8 mM) was restored at 180 s. The
graphs represent the average of 103 to 165 cells from one
representative experiment. B, CCh-induced net Ca
2+ entry (average of
[Ca
2+]i values after 174–177 s subtracted from [Ca
2+]i values after 222–
228 s) were calculated and graphed as averages 6 SD of six
independent experiments. * P,0.01.
doi:10.1371/journal.pone.0018121.g003
Figure 4. The mutation of Ser
814 into Ala does not modify the
level of expression nor the trafficking of TRPC6. TRPC6 and
TRPC
S814A were transfected in HEK293T cells. The cells were biotinylated
with sulfo-NHS-SS-biotin, lysed, and incubated with streptavidin-
agarose beads as described in Experimental Procedures. Proteins
precipitated by streptavidin-agarose were separated by SDS-PAGE
and detected with an anti-HA antibody (top). Aliquots of the cell lysates
were collected before the incubation with streptavidin-agarose and
analyzed directly by immunoblotting to determine the total amount of
TRPC6 (middle) and actin (bottom) in the samples. Representative
immunoblot of three independent experiments.
doi:10.1371/journal.pone.0018121.g004
Figure 5. CK2 does not phosphorylate TRPC6. A, T6.11 cells were
labeled in the presence or not of 10 mM DMAT or 10 mM TBCA for 4 h
before the cells were lysed and TRPC6 was immunoprecipitated and
separated by SDS-PAGE. The autoradiogram is representative of six
independent experiments. B, The densitometric analyses of autoradio-
grams and Western blots (not shown) from A and the calculated ratios
are relative to the control (100%). The histogram represents the average
6 SD of six independent experiments.
doi:10.1371/journal.pone.0018121.g005
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cleavages were allowed.
Criteria for protein identification. Scaffold (version
2.00.05, Proteome Software Inc., Portland, OR, USA) was used
to validate MS/MS-based peptide and protein identifications.
Peptide identifications were accepted if they exceeded 95%
probability as specified by the Peptide Prophet algorithm [16].
Protein identifications were accepted if they exceed 95%
probability and contained at least two identified peptides.
Protein probabilities were assigned by the Protein Prophet
algorithm [17]. Proteins that contained similar peptides and
could not be differentiated based on the MS/MS analysis alone
were grouped to satisfy the principles of parsimony. For
phosphopeptides, a pronounced neutral loss of phosphoric acid
from the precursor ion and/or fragment ions was required as well
as extensive coverage of the b and y series. In addition, the
phosphopeptide spectra were submitted to Ascore to identify the
phosphorylation site(s) on the peptide. Ascore measures the
probability of correct phosphorylation site localization based on
the presence and intensity of site-determining ions in MS/MS
spectra [18].
Molecular biology
Standard molecular biology techniques were used to isolate,
analyze, and clone DNA [19,20]. Point mutations in mouse
TRPC6 were introduced using a PCR-based site-directed
mutagenesis approach. The PCR fragments were subcloned and
amplified in the pCR-BluntII-TOPO vector using a Zero Blunt
TOPO PCR cloning kit. The fragments were sequenced and
reinserted into HA-tagged TRPC6 in pcDNA3.1 using the
appropriate restriction enzymes and T4 DNA ligase. All constructs
were confirmed by sequencing from double-stranded DNA
templates using the dideoxynucleotide termination method [21].
Cell culture and transfection
HEK293T cells and A7r5 vascular myocytes were maintained
at subconfluence in DMEM supplemented with 10% fetal bovine
serum, 50 U/ml of penicillin, and 50 mg/ml of streptomycin at
37uC in a humidified atmosphere containing 5% CO2. T6.11 cells
(HEK293 stably transfected with mouse TRPC6) [4] were
cultured in the same medium supplemented with 400 mg/ml
G418. For transient transfections, six-well plates were treated with
0.1 mg/ml poly-L-lysine for 30 min, rinsed with PBS (137 mM
NaCl, 3.5 mM KCl, 10 mM sodium phosphate buffer, pH 7.4),
and air-dried. Plasmid DNA (1 mg) in 250 mL Opti-MEM I was
placed in each well, to which 2.5 mL of LipofectAMINE 2000
diluted in 250 ml of Opti-MEM I was added and thoroughly
mixed. After a 20 min incubation, 8610
5 HEK293T cells diluted
in 1.5 ml of culture medium without antibiotics were added to
each well. The cells were incubated for 16 h at 37uCi na
humidified atmosphere containing 5% CO2. Twenty-four hours
after the transfection, the cells from one well were transferred into
a 60-mm Petri dish for metabolic labeling assays or deposited on
three poly-L-lysine-treated coverslips for [Ca
2+]i measurements.
Metabolic labeling
Stably or transiently transfected cells grown in 60 mm Petri
dishes were washed once with phosphate-free DMEM and
incubated for 4 h in phosphate-free DMEM supplemented with
250 mCi/ml of
32P-inorganic phosphate. The cells were then
washed twice on ice with ice-cold PBS-EDTA (137 mM NaCl,
3.5 mM KCl, 1 mM EDTA, 17.4 mM Na2HPO4, 3.5 mM
NaH2PO4) prior to being lysed.
Immunoprecipitation and protein separation
The cells were lysed with 1 ml of ice-cold lysis buffer (1.25%
NP-40, 1.25% sodium deoxycholate, 2 mM EDTA, 12.5 mM
sodium phosphate, pH 7.2, 1 mg/ml of soybean trypsin inhibitor,
5 mg/ml of leupeptin, 100 mM phenylmethylsulfonyl fluoride)
supplemented with a phosphatase inhibitor cocktail for 30 min on
Figure 6. The inhibition of CK2 with specific inhibitors does not
alter TRPC6 activity. A, Fura-2-loaded T6.11 cells were left untreated
(circles) or were treated for 4 h with 10 mM DMAT (squares) or 10 mM
TBCA (triangles). CCh (5 mM) induced Ca
2+ release in the absence of
extracellular Ca
2+ while Ca
2+ restoration 2 min later induced Ca
2+ entry.
DMAT and TBCA concentrations were maintained during the assay. The
graphs are representative of 176 to 227 cells from one typical
experiment. B, Net maximal Ca
2+ entries from A were calculated as in
Figure 3 and are relative to the control (100%). The histogram
represents the average 6 SD of four independent experiments. C,
The same protocol was carried out on A7r5 cells using 100 nM AVP
instead of CCh. The net maximal Ca
2+ entry was calculated relative to
the control (100%). The histogram is the average 6 SD of three
independent experiments.
doi:10.1371/journal.pone.0018121.g006
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of the Petri dish and centrifuged at 15 0006g for 15 min at 4uC.
The supernatant was collected and immunoprecipitated with 50 ml
of protein A-sepharose beads (50% slurry) and anti-HA rabbit
antibody (1:1000) for 2 h at 4uC. The samples were then
centrifuged for 1 min at 4uC at 8006g and washed twice with
500 ml of ice-cold lysis buffer. Immunoprecipitated proteins were
dissolved in 40 ml of 2X Laemmli buffer and boiled for 5 min
before being separated on 8% SDS-polyacrylamide gels. The gels
were then either stained, dried, and exposed to a film for
autoradiography, or the protein bands were transferred onto a
0.2 mm nitrocellulose membrane (400 mA for 2 h or 100 mA
overnight in 150 mM glycine, 20 mM Tris-base, 20% methanol)
for immunoblotting. For MS/MS analyses, stained bands
corresponding to TRPC6 were excised.
Immunoblots
The nitrocellulose membranes to which the whole cell lysates
and immunoprecipitated proteins had been transferred were
stained with Ponceau S (0.1% in 5% acetic acid) to visualize the
marker proteins, destained in TBST (20 mM Tris-HCl, pH 7.5,
137 mM NaCl, 0.1% Tween 20) and blocked in TBST containing
5% (w/v) nonfat dry milk for either 1 h at room temperature or
overnight at 4uC. The membranes were then washed and
incubated in TBST for 2.5 h at room temperature or overnight
at 4uC with specific primary antibodies (mouse anti-HA 1:1000).
After three washes with TBST, the membranes were incubated for
1.5 h at room temperature with TBST containing 1:10 000
peroxidase-conjugated sheep anti-mouse IgG. The blots were
washed three times with TBST, and the immune complexes were
detected with a Western Lightning Chemiluminescence Reagent
Plus kit using the manufacturer’s protocol.
Measurement of [Ca
2+]i
We used the method described by Zhu et al. [22] to measure
[Ca
2+]i. Briefly, T6.11 [4], A7r5 (ATCC), or transfected
HEK293T (ATCC) cells grown on poly-L-lysine-treated coverslips
were washed twice with HBSS (120 mM NaCl, 5.3 mM KCl,
0.8 mM MgSO4, 10 mM glucose, 1.8 mM CaCl2, 20 mM Hepes,
pH 7.4) and loaded with fura 2/AM (1.5 mM in HBSS) for 20 min
at room temperature in the dark. After washing and de-esterifying
in fresh HBSS for 20 min at room temperature, the coverslips
were inserted in a circular open-bottom chamber and placed on
the stage of a Zeiss Axovert microscope fitted with an Attofluor
Digital Imaging and Photometry System (Attofluor Inc., Rockville,
MD, USA). Isolated fura 2-loaded cells were selected and their
[Ca
2+]i were measured by fluorescence videomicroscopy at room
temperature using alternating excitation wavelengths of 334 and
380 nm (10 nm bandpass filters). Emitted fluorescence was
monitored through a 510 nm dichroic mirror and a 520 nm long
pass filter set. Free [Ca
2+]i was calculated from the 334/380
fluorescence ratio using the method of Grynkiewicz et al. [23].
Reagents were diluted to their final concentrations in HBSS and
applied to the cells by surface perfusion. Ca
2+-free HBSS was
supplemented with 0.5 mM EGTA to chelate any remaining
extracellular Ca
2+. For the transient transfections, cells were co-
transfected with cDNA encoding the M5 muscarinic receptor, and
only those responding to CCh were analyzed. [Ca
2+]i values were
recorded every 3 s.
Author Contributions
Conceived and designed the experiments: SMB MM GB. Performed the
experiments: SMB MM. Analyzed the data: SMB MM GB. Wrote the
paper: SMB GB.
References
1. Berridge MJ, Lipp P, Bootman MD (2000) The versatility and universality of
calcium signalling. Nature Reviews Molecular Cell Biology 1: 11–21.
2. Nilius B, Owsianik G, Voets T, Peters JA (2007) Transient receptor potential
cation channels in disease. Physiological Reviews 87: 165–217.
3. Liao Y, Erxleben C, Yildirim E, Abramowitz J, Armstrong DL, et al. (2007) Orai
proteins interact with TRPC channels and confer responsiveness to store
depletion. Proceedings of the National Academy of Sciences of the United States
of America 104: 4682–4687.
4. Boulay G, Zhu X, Peyton M, Jiang MS, Hurst R, et al. (1997) Cloning and
expression of a novel Mammalian homolog of Drosophila transient receptor potential
(Trp) involved in calcium entry secondary to activation of receptors coupled by the
G(q) class of G protein. Journal of Biological Chemistry 272: 29672–29680.
5. Yu Y, Fantozzi L, Remillard CV, Landsberg JW, Kunichika N, et al. (2004)
Enhanced expression of transient receptor potential channels in idiopathic
pulmonary arterial hypertension. Proceedings of the National Academy of
Sciences of the United States of America 101: 13861–13866.
6. Yu Y, Keller S, Remillard C, Safrina O, Nicholson A, et al. (2009) A functional
single-nucleotide polymorphism in the TRPC6 gene promoter associated with
idiopathic pulmonary arterial hypertension. Circulation 119: 2313–2322.
7. Winn MP, Conlon PJ, Lynn KL, Farrington MK, Creazzo T, et al. (2005) A
mutation in the TRPC6 cation channel causes familial focal segmental
glomerulosclerosis. Science 308: 1801–1804.
8. Reiser J, Polu KR, Moller CC, Kenlan P, Altintas MM, et al. (2005) TRPC6 is a
glomerular slit diaphragm-associated channel required for normal renal
function. Nature Genetics 37: 739–744.
9. El Boustany C, Bidaux G, Enfissi A, Delcourt P, Prevarskaya N, et al. (2008)
Capacitative calcium entry and transient receptor potential canonical 6
expression control human hepatoma cell proliferation. Hepatology 47:
2068–2077.
10. Hisatsune C, Kuroda Y, Nakamura K, Inoue T, Nakamura T, et al. (2004)
Regulation of TRPC6 channel activity by tyrosine phosphorylation. Journal of
Biological Chemistry 279: 18887–18894.
11. Takahashi S, Lin H, Geshi N, Mori Y, Kawarabayashi Y, et al. (2008) Nitric
oxide-cGMP-protein kinase G pathway negatively regulates vascular transient
receptor potential channel TRPC6. J Physiol 586: 4209–4223.
12. Kim JY, Saffen D (2005) Activation of M1 muscarinic acetylcholine receptors
stimulates the formation of a multiprotein complex centered on TRPC6
channels. Journal of Biological Chemistry 280: 32035–32047.
13. Bousquet S, Monet M, Boulay G (2010) Protein kinase C-dependent
phosphorylation of transient receptor potential canonical 6 (TRPC6) on serine
448 causes channel inhibition. Journal of Biological Chemistry.
14. Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric
sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68: 850–858.
15. Havlis J, Thomas H, Sebela M, Shevchenko A (2003) Fast-response proteomics
by accelerated in-gel digestion of proteins. Anal Chem 75: 1300–1306.
16. Keller A, Nesvizhskii A, Kolker E, Aebersold R (2002) Empirical statistical
model to estimate the accuracy of peptide identifications made by MS/MS and
database search. Anal Chem 74: 5383–5392.
17. Nesvizhskii A, Keller A, Kolker E, Aebersold R (2003) A statistical model for
identifying proteins by tandem mass spectrometry. Anal Chem 75: 4646–4658.
18. Beausoleil S, Ville ´n J, Gerber S, Rush J, Gygi S (2006) A probability-based
approach for high-throughput protein phosphorylation analysis and site
localization. Nat Biotechnol 24: 1285–1292.
19. Sambrook J, Russell DW (2001) Molecular Cloning: A Laboratory Manual;
Press CSHL, editor. New York: Cold Spring Harbor.
20. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, et al. (2002)
Current Protocols in Molecular Biology. New York: Green Publishing Associates
and Wiley Interscience.
21. Sanger F, Nicklen S, Coulson A (1977) DNA sequencing with chain-terminating
inhibitors. Proc Natl Acad Sci U S A 74: 5463–5467.
22. Zhu X, Jiang MS, Peyton M, Boulay G, Hurst R, et al. (1996) trp, a novel
mammalian gene family essential for agonist-activated capacitative Ca2+ entry.
Cell 85: 661–671.
23. Grynkiewicz G, Poenie M, Tsien R (1985) A new generation of Ca2+ indicators
with greatly improved fluorescence properties. Journal of Biological Chemistry
260: 3440–3450.
24. Meggio F, Marin O, Pinna L (1994) Substrate specificity of protein kinase CK2.
Cell Mol Biol Res 40: 401–409.
25. Jung S, Strotmann R, Schultz N, Plant TD (2002) TRPC6 is a candidate
channel involved in receptor-stimulated cation currents in A7r5 smooth muscle
cells. American Journal of Physiology-Cell Physiology 282: C347–C359.
26. Soboloff J, Spassova M, Xu W, He LP, Cuesta N, et al. (2005) Role of
endogenous TRPC6 channels in Ca2+ signal generation in A7r5 smooth muscle
cells. Journal of Biological Chemistry 280: 39786–39794.
27. Mani B, Brueggemann L, Cribbs L, Byron K (2009) Opposite regulation of
KCNQ5 and TRPC6 channels contributes to vasopressin-stimulated calcium
Basal Phosphorylation of Serine 814 of TRPC6
PLoS ONE | www.plosone.org 7 March 2011 | Volume 6 | Issue 3 | e18121spiking responses in A7r5 vascular smooth muscle cells. Cell Calcium 45:
400–411.
28. Bousquet S, Monet M, Boulay G (2010) Protein kinase C-dependent
phosphorylation of transient receptor potential canonical 6 (TRPC6) on serine
448 causes channel inhibition. J Biol Chem.
29. Hassock S, Zhu M, Trost C, Flockerzi V, Authi K (2002) Expression and role of
TRPC proteins in human platelets: evidence that TRPC6 forms the store-
independent calcium entry channel. Blood 100: 2801–2811.
30. Voolstra O, Beck K, Oberegelsbacher C, Pfannstiel J, Huber A (2010) Light-
dependent phosphorylation of the drosophila transient receptor potential ion
channel. J Biol Chem 285: 14275–14284.
31. Sinkins WG, Goel M, Estacion M, Schilling WP (2004) Association of
immunophilins with mammalian TRPC channels. Journal of Biological
Chemistry 279: 34521–34529.
32. Boulay G, Brown DM, Qin N, Jiang MS, Dietrich A, et al. (1999) Modulation of
Ca2+ entry by polypeptides of the inositol 1,4,5-trisphosphate receptor (IP3R)
that bind transient receptor potential (TRP): Evidence for roles of TRP and
IP3R in store depletion-activated Ca2+ entry. Proceedings of the National
Academy of Sciences of the United States of America 96: 14955–14960.
33. Boulay G (2002) Ca2+-calmodulin regulates receptor-operated Ca2+ entry
activity of TRPC6 in HEK-293 cells. Cell Calcium 32: 201–207.
34. Tang J, Lin YK, Zhang ZM, Tikunova S, Birnbaumer L, et al. (2001)
Identification of common binding sites for calmodulin and inositol 1,4,5-
trisphosphate receptors on the carboxyl termini of Trp channels. Journal of
Biological Chemistry 276: 21303–21310.
35. Ko ¨ttgen M, Benzing T, Simmen T, Tauber R, Buchholz B, et al. (2005)
Trafficking of TRPP2 by PACS proteins represents a novel mechanism of ion
channel regulation. EMBO J 24: 705–716.
36. Cai Y, Anyatonwu G, Okuhara D, Lee K, Yu Z, et al. (2004) Calcium
dependence of polycystin-2 channel activity is modulated by phosphorylation at
Ser812. J Biol Chem 279: 19987–19995.
37. Chung H, Huang Y, Lau L, Huganir R (2004) Regulation of the NMDA
receptor complex and trafficking by activity-dependent phosphorylation of the
NR2B subunit PDZ ligand. J Neurosci 24: 10248–10259.
38. Sarker R, Grønborg M, Cha B, Mohan S, Chen Y, et al. (2008) Casein kinase 2
binds to the C terminus of Na+/H+ exchanger 3 (NHE3) and stimulates NHE3
basal activity by phosphorylating a separate site in NHE3. Mol Biol Cell 19:
3859–3870.
39. Bildl W, Strassmaier T, Thurm H, Andersen J, Eble S, et al. (2004) Protein
kinase CK2 is coassembled with small conductance Ca(2+)-activated K+
channels and regulates channel gating. Neuron 43: 847–858.
Basal Phosphorylation of Serine 814 of TRPC6
PLoS ONE | www.plosone.org 8 March 2011 | Volume 6 | Issue 3 | e18121